- SLXP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $108.7 million.
- SLXP is down 2.7% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SLXP with the Ticky from Trade-Ideas. See the FREE profile for SLXP NOW at Trade-Ideas More details on SLXP: Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. SLXP has a PE ratio of 120.4. Currently there are 8 analysts that rate Salix Pharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Salix Pharmaceuticals has been 1.1 million shares per day over the past 30 days. Salix has a market cap of $8.7 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.14 and a short float of 17.3% with 9.27 days to cover. Shares are up 53% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.